EXPRESSION OF THE NEUROFIBROMATOSIS-I GENE-PRODUCT, NEUROFIBROMIN, IN BLOOD-VESSEL ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE

被引:75
作者
NORTON, KK
XU, J
GUTMANN, DH
机构
[1] UNIV WASHINGTON,SCH MED,CTR STUDY NERVOUS SYST INJURY,ST LOUIS,MO
[2] UNIV WASHINGTON,SCH MED,DEPT NEUROL,ST LOUIS,MO
[3] UNIV WASHINGTON,SCH MED,DEPT PEDIAT,ST LOUIS,MO
[4] UNIV WASHINGTON,SCH MED,DEPT GENET,ST LOUIS,MO
关键词
BISPECIFIC; CANCER THERAPY; SINGLE CHAIN ANTIBODIES;
D O I
10.1006/nbdi.1995.0002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Vascular pathology is an underestimated complication of neurofibromatosis 1 (NF1). Manifestations include renovascular stenosis with associated hypertension, cerebrovascular occlusion, visceral ischaemia and aneurysms of smaller arteries. This is illustrated by a woman recently evaluated in our Neurofibromatosis Program who had multiple cerebrovascular and renovascular abnormalities. To determine the contribution of NF1 expression to NF1 vasculopathy, the expression of the NF1 gene product, neurofibromin, was examined in blood vessels. Neurofibromin was detected in the endothelial cell layer of rat cerebral vessels, renal arteries, and aorta by immunohistochemistry. Cultured bovine cerebral endothelial cells were found to express NF1 mRNA by RT-PCR and neurofibromin by Western immunoblotting and immunocytochemistry. Neurofibromin expression was also detected in the smooth muscle layer of the aorta but not of cerebral or renal vessels. The vascular abnormalities of NF1 are reviewed and possible pathogenesis with respect to neurofibromin expression is discussed.
引用
收藏
页码:13 / 21
页数:9
相关论文
共 32 条
  • [21] DIFFERENTIAL EXPRESSION AND TISSUE DISTRIBUTION OF TYPE-I AND TYPE-II NEUROFIBROMINS DURING MOUSE FETAL DEVELOPMENT
    HUYNH, DP
    NECHIPORUK, T
    PULST, SM
    [J]. DEVELOPMENTAL BIOLOGY, 1994, 161 (02) : 538 - 551
  • [22] NEUROFIBROMIN CAN INHIBIT RAS-DEPENDENT GROWTH BY A MECHANISM INDEPENDENT OF ITS GTPASE-ACCELERATING FUNCTION
    JOHNSON, MR
    DECLUE, JE
    FELZMANN, S
    VASS, WC
    XU, GF
    WHITE, R
    LOWY, DR
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (01) : 641 - 645
  • [23] THE GAP-RELATED DOMAIN OF THE NEUROFIBROMATOSIS TYPE-1 GENE-PRODUCT INTERACTS WITH RAS P21
    MARTIN, GA
    VISKOCHIL, D
    BOLLAG, G
    MCCABE, PC
    CROSIER, WJ
    HAUBRUCK, H
    CONROY, L
    CLARK, R
    OCONNELL, P
    CAWTHON, RM
    INNIS, MA
    MCCORMICK, F
    [J]. CELL, 1990, 63 (04) : 843 - 849
  • [24] MOORE SA, 1990, AM J PHYSIOL, V254, pC37
  • [25] REUBI F, 1945, SCHWEIZ MED WSCHR, V75, P463
  • [26] NEUROFIBROMATOSIS - PAST, PRESENT, AND FUTURE
    RICCARDI, VM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (18) : 1283 - 1285
  • [27] RICCARDI VM, 1992, NEUROFIBROMATOSIS PH, P119
  • [28] SAHAGUN G, 1989, AM J PATHOL, V134, P1227
  • [29] VASCULAR-LESIONS OF NEUROFIBROMATOSIS
    SALYER, WR
    SALYER, DC
    [J]. ANGIOLOGY, 1974, 25 (08) : 510 - 519
  • [30] TSUKADA T, 1987, AM J PATHOL, V126, P51